These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10994663

  • 1. Association of prostate-specific antigen levels and patterns of benign and malignant uptake detected. on bone scintigraphy in patients with newly diagnosed prostate carcinoma.
    Jacobson AF.
    Nucl Med Commun; 2000 Jul; 21(7):617-22. PubMed ID: 10994663
    [Abstract] [Full Text] [Related]

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Jul; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of serum prostate specific antigen levels and bone scintigraphy in patients with prostate carcinoma].
    Bielickaite J, Zadeikaite R, Jurkiene N, Kiudelis J, Kuprionis G.
    Medicina (Kaunas); 2003 Jul; 39(9):867-71. PubMed ID: 14515049
    [Abstract] [Full Text] [Related]

  • 4. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L, Adjinovic B, Cerovic S, Joksimovic M, Soldatovic Z.
    Hell J Nucl Med; 2011 Jul; 14(2):126-30. PubMed ID: 21761013
    [Abstract] [Full Text] [Related]

  • 5. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
    Pal RP, Thiruudaian T, Khan MA.
    Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
    [Abstract] [Full Text] [Related]

  • 6. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
    Bruwer G, Heyns CF, Allen FJ.
    Eur Urol; 1999 Nov; 35(3):223-7. PubMed ID: 10072624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
    Begic A, Kucukalic-Selimovic E, Obralic N, Duric O, Lacevic N, Begovic-Hadzimuratovic S, Skopljak A, Dzubur-Aganovic M.
    Med Arh; 2006 Nov; 60(1):54-5. PubMed ID: 16425536
    [Abstract] [Full Text] [Related]

  • 16. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?
    Vijayakumar V, Vijayakumar S, Quadri SF, Blend MJ.
    Am J Clin Oncol; 1994 Oct; 17(5):432-6. PubMed ID: 7522394
    [Abstract] [Full Text] [Related]

  • 17. A reappraisal of serial isotope bone scans in prostate cancer.
    O'Donoghue JM, Rogers E, Grimes H, McCarthy P, Corcoran M, Bredin H, Given HF.
    Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.